Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to announce that, further to its news release dated June 28, 2018, it has closed its investment in XLABS Therapeutics (ONT) Inc. (“XLABS”).
Read more
Abattis Completes Investment in XLABS Therapeutics to Launch New Cannabis Lab in Ontario
